Homepage
Upcoming Webinars: Peptide Drug Discovery and Development
Our two-part webinar series on July 9th and 10th showcases strategies for peptide screening and ligand validation, preclinical safety assessment, and DMPK/bioanalytical solutions
Integrated Direct-to-Biology (D2B) Platform
Learn how our D2B platform can streamline iterative design-synthesis-test cycles by directly testing high-throughput synthesized compounds in biological assays
Article: Innovative R&D Strategies for Peptide Drugs in Obesity Treatment
Learn about multi-target combination approaches and muscle-preserving weight loss strategies demonstrated through case studies
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Severe Hyperglycemia and Hyperlipidemia Alter Tumor Growth and Immune Profiles
VIEW PosterAlterations in Energy Metabolism and Lipogenesis in GIPR/GLP-1R Agonist-Treated MASH Mice
VIEW PosterLatest Poster
Precision-Cut Tissue Slices to Advance Drug Discovery
Precision-Cut Tissue Slices
VIEW PosterNovel ROR1 Antibody with High Specificity and Sensitivity
VIEW PosterLatest Poster
Development of NK Humanized Mouse Models
Development of NK Humanized Mouse Models
VIEW PosterLatest Poster
Isogeneic Trop-2 Model for Evaluating Anti-Trop-2 ADCs
Isogeneic Trop-2 Model for Evaluating Anti-Trop-2 ADCs
VIEW PosterLatest Poster
HPV18-Related Cancer Model Development
HPV18-Related Cancer Model Development
VIEW PosterLatest Publication
DNA-Compatible Huisgen Cycloaddition
DNA-Compatible Huisgen Cycloaddition
VIEW Publication